semaglutide compounding news november 2025 The Shortage Is Ending: What's Next For Compounded Drugs? Compounded "semaglutide" is not FDA-approved

Those with lactose intolerance should select lactose-free dairy options or plant alternatives

Hormonal disorders such as untreated hypothyroidism, Cushing's syndrome, or polycystic ovary syndrome (PCOS) can impair metabolic responses to semaglutide

Many users inject it in abdominal fat for convenience regardless of injury location

Meal spacing that creates clear hungersatiety cycles can help some people notice fullness cues more reliably

However, individual tolerability and safety to GLP-1RA may vary due to differences in molecular structures (77)

The mechanism of action involves binding to GLP-1 receptors located throughout the body, including the pancreas, gastrointestinal tract, and importantly, the brain